Definitive Contract HHSD200201690101C
Award Date
7/1/16
Potential Completion Date
6/30/17
Potential Value
$37M
Federal Agency
CDC Pittsburgh
Awardee
Pfizer Inc.
Ultimate Awardee
Not listed
NAICS Category
325411 - Medicinal and Botanical Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Atlanta, GA 30329, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
5
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $41,402,500.00 firm fixed price definitive contract awarded to Pfizer Inc. (Pfizer) by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) for the provision of adult vaccines. The contract has a performance period ending on June 30, 2018, with no set-aside designation mentioned. As the prime contractor, Pfizer will be directly delivering the vaccines without the involvement of major subcontractors. The vaccines to be supplied include those for...
This is a firm fixed-price definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Pfizer Inc. for the supply of adult vaccines. The contract has a ceiling value of $54,499,343.31 and an ultimate completion date of June 30, 2016. The contract does not have a set-aside designation. Pfizer, the prime contractor, is a global pharmaceutical corporation that plays a significant role in supplying medical products and services to the U.S. federal government. This contract...
This is a $21,494,073,684.68 Definitive, Firm Fixed Price contract awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to Pfizer Inc. (Wyeth Division) for a pediatric vaccine program. The contract has an ultimate completion date of March 31, 2011 and was not set aside. This contract appears to be part of the CDC's Vaccines for Children (VFC) program, which provides vaccines at no cost to children who might not otherwise be vaccinated because of...
This is a $8,650,565,549.53 Firm Fixed Price definitive contract awarded to Pfizer Inc. by the Office of the Assistant Secretary for Preparedness and Response (ASPR) for the provision of COVID-19 vaccines. The contract has an ultimate completion date of May 29, 2024 and was awarded on October 1, 2022 without any set-aside designation. Pfizer, a global pharmaceutical manufacturer, is the prime contractor for this award. The contract supports the government's COVID-19 vaccine initiatives and is...
This is a $924,719.33 firm-fixed-price delivery order awarded by the Defense Logistics Agency Troop Support Medical to Pfizer Inc. The contract will run through September 30, 2025 and provides for the supply of various pharmaceuticals and medical products, including controlled substances, antibiotics, and vaccines. Pfizer, a global pharmaceutical corporation, serves as the prime contractor on this award. The contract is not set-aside and Pfizer has been awarded several significant Indefinite...
This is a federal contract award to Pfizer Inc., a global pharmaceutical company, by the U.S. Department of Veterans Affairs (VA) to provide pharmaceutical products, including prescription medications, vaccines, and other critical medical supplies, to support healthcare initiatives across multiple government agencies. The contract, a Blanket Purchase Agreement (BPA) call, has a ceiling value of $123,024.60 and runs from October 1, 2016, to September 30, 2017. The contract is not set aside and is...
This is a $481,836 firm fixed-price delivery order awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency, to Pfizer Inc. The order is for life-saving pharmaceuticals to backfill cache kits. The contract is under the General Services Administration (GSA) Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and does not have a set-aside designation. Pfizer, a large pharmaceutical manufacturer, is a major provider of prescription drugs,...
This is a $6,859,517,906.00 firm fixed-price definitive contract awarded by the Bureau for Global Health, a civilian agency within the U.S. government, to Pfizer Inc. for the provision of COVID-19 vaccines for international donation. The contract has an ultimate completion date of February 29, 2024 and does not utilize any set-aside designations. Pfizer is the prime contractor for this award, which is associated with the company's existing Vaccines for Children (VFC) program contract with the...
This is a Firm Fixed Price delivery order contract awarded by the Centers for Disease Control and Prevention (CDC) to Pfizer Inc., a large pharmaceutical manufacturer. The $2,201,243.29 contract is for the storage and rotation of Pfizer vaccines. The contract has an ultimate completion date of July 31, 2027. This contract is not set aside for small businesses. Pfizer is the prime contractor, and there are no major subcontractors mentioned. The contract is part of the CDC's broader efforts to...
This is a firm fixed-price delivery order awarded to Pfizer Inc. by the Defense Logistics Agency Troop Support Medical in the amount of $347,362.79. The contract has no set-aside designation. Pfizer, a large pharmaceutical company, will provide a variety of pharmaceutical products to U.S. government agencies, including COVID-19 vaccines, intravenous solutions, injections, vaccines, controlled substances, and other medical supplies. Pfizer also holds a Blanket Purchase Agreement against the...